Intellectual Property - July 4, 2015
ITC Investigating Complaint Against Novo Nordisk
A complaint by Baxter back in March that Novo Nordisk’s recently launched hemophilia drug infringed on some of Baxter’s patents prompted an investigation this week by the U.S. International Trade Commission. On Wednesday, Novo Nordisk disputed Baxter’s claims that its Novoeight used substances Baxter developed, Reuters reports, and it told the news service it had […]